Mumbai, India, June 2025 — Aditi Pai has been appointed as the Chief Financial Officer of Transasia Bio-Medicals Ltd., marking a significant step in the company’s financial leadership during a critical phase of its growth in the diagnostics and medical devices sector. A seasoned finance professional, Aditi brings over 14 years of experience across healthcare, e-commerce, and consulting industries.
Aditi joined Transasia in February 2024 as Head of Finance, where she quickly demonstrated strategic leadership and deep domain expertise in financial planning, governance, and compliance. Her rapid elevation to CFO reflects her strong alignment with the company’s vision and her ability to lead financial transformation in high-growth environments.
Prior to Transasia, she served as Chief Financial Officer at BEWAKOOF®.com for nearly four years. In this role, she oversaw financial reporting, audits, compliance, and corporate governance while also leading the beauty business vertical as Business Head – COSMOS Beauty. Her tenure was marked by expansion in product categories and enhanced financial systems.
Earlier, Aditi worked as Finance Controller at Purplle.com, a rapidly growing beauty tech platform. She was instrumental in financial restructuring and building robust reporting mechanisms. Before this, she spent two years at SNC-Lavalin as Assistant Finance Controller and Company Secretary, where she led statutory compliance and financial governance initiatives.
Aditi began her career with PwC, where she progressed from an article assistant to assistant manager over six years. She gained a strong foundation in external audits, tax, and regulatory frameworks, supporting clients across sectors. A Chartered Accountant and ACCA diploma holder, Aditi is also an active angel investor, advising and funding early-stage startups.
Her appointment underscores Transasia Bio-Medicals Ltd.’s commitment to building agile, future-ready leadership as the company continues to innovate and scale its footprint in India and globally.
Transasia Bio-Medicals Ltd.
Established in 1979 and headquartered in Mumbai, Transasia Bio-Medicals Ltd. is India’s largest In-vitro Diagnostic (IVD) company. It offers world-class diagnostic solutions in areas such as Clinical Chemistry, Hematology, Immunology, Blood Banking, Urinalysis, Diabetes Management, and Molecular Diagnostics. Known for accuracy and innovation, Transasia partners with leading hospitals and diagnostic labs across the globe, and continues to shape the future of healthcare diagnostics through sustainable, reliable, and accessible technologies.
Read Also : HR Is Not a Support Function—It’s the CEO’s Most Powerful Growth Engine
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
From Gatekeeping to Gateway Building: Transforming How Organisations Create Access
Leadership In Talent Management: A Powerful Driver for Economic Growth
